P J Van Galen - JoVE Visualize

Showing results (11-20 of 20) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 20 results.

European Journal of Pharmacology|April 25, 1991

Mapping the xanthine C8-region of the adenosine A1 receptor with computer graphicsE M Van der Wenden, P J Van Galen, A P IJzerman, et al.

European Journal of Pharmacology|June 15, 1994

Molecular modeling of adenosine receptors. The ligand binding site on the rat adenosine A2A receptorA P IJzerman, E M van der Wenden, P J van Galen, et al.

Journal of Medicinal Chemistry|May 14, 1993

Structure-activity relationships of 8-styrylxanthines as A2-selective adenosine antagonistsK A Jacobson, C Gallo-Rodriguez, N Melman, et al.

Proceedings of the National Academy of Sciences of the United States of America|June 15, 1992

A1 adenosine-receptor antagonists activate chloride efflux from cystic fibrosis cellsO Eidelman, C Guay-Broder, P J van Galen, et al.

Biochemistry|July 18, 1995

Stimulation by alkylxanthines of chloride efflux in CFPAC-1 cells does not involve A1 adenosine receptorsK A Jacobson, C Guay-Broder, P J van Galen, et al.

Molecular Pharmacology|June 1, 1994

A binding site model and structure-activity relationships for the rat A3 adenosine receptorP J van Galen, A H van Bergen, C Gallo-Rodriguez, et al.

Bioorganic & Medicinal Chemistry Letters|April 14, 1999

1-Aminoisoquinoline as benzamidine isoster in the design and synthesis of orally active thrombin inhibitorsJ B Rewinkel, H Lucas, P J van Galen, et al.

Journal of Medicinal Chemistry|March 4, 1994

Structure-activity relationships of N6-benzyladenosine-5'-uronamides as A3-selective adenosine agonistsC Gallo-Rodriguez, X D Ji, N Melman, et al.

Journal of Medicinal Chemistry|October 30, 1992

Synthesis and biological activity of N6-(p-sulfophenyl)alkyl and N6-sulfoalkyl derivatives of adenosine: water-soluble and peripherally selective adenosine agonistsK A Jacobson, O Nikodijevic, X D Ji, et al.

Rheumatology (Oxford, England)|January 4, 2001

Cellular immune response to human cartilage glycoprotein-39 (HC gp-39)-derived peptides in rheumatoid arthritis and other inflammatory conditionsK Vos, A M Miltenburg, K E van Meijgaarden, et al.

Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 20 results.

European Journal of Pharmacology|April 25, 1991

Mapping the xanthine C8-region of the adenosine A1 receptor with computer graphicsE M Van der Wenden, P J Van Galen, A P IJzerman, et al.

European Journal of Pharmacology|June 15, 1994

Molecular modeling of adenosine receptors. The ligand binding site on the rat adenosine A2A receptorA P IJzerman, E M van der Wenden, P J van Galen, et al.

Journal of Medicinal Chemistry|May 14, 1993

Structure-activity relationships of 8-styrylxanthines as A2-selective adenosine antagonistsK A Jacobson, C Gallo-Rodriguez, N Melman, et al.

Proceedings of the National Academy of Sciences of the United States of America|June 15, 1992

A1 adenosine-receptor antagonists activate chloride efflux from cystic fibrosis cellsO Eidelman, C Guay-Broder, P J van Galen, et al.

Biochemistry|July 18, 1995

Stimulation by alkylxanthines of chloride efflux in CFPAC-1 cells does not involve A1 adenosine receptorsK A Jacobson, C Guay-Broder, P J van Galen, et al.

Molecular Pharmacology|June 1, 1994

A binding site model and structure-activity relationships for the rat A3 adenosine receptorP J van Galen, A H van Bergen, C Gallo-Rodriguez, et al.

Bioorganic & Medicinal Chemistry Letters|April 14, 1999

1-Aminoisoquinoline as benzamidine isoster in the design and synthesis of orally active thrombin inhibitorsJ B Rewinkel, H Lucas, P J van Galen, et al.

Journal of Medicinal Chemistry|March 4, 1994

Structure-activity relationships of N6-benzyladenosine-5'-uronamides as A3-selective adenosine agonistsC Gallo-Rodriguez, X D Ji, N Melman, et al.

Journal of Medicinal Chemistry|October 30, 1992

Rheumatology (Oxford, England)|January 4, 2001

Cellular immune response to human cartilage glycoprotein-39 (HC gp-39)-derived peptides in rheumatoid arthritis and other inflammatory conditionsK Vos, A M Miltenburg, K E van Meijgaarden, et al.

Pageof 2